Status:
COMPLETED
Oral Corticosteroids' Role in Pediatric Obstructive Sleep Apnea
Lead Sponsor:
Hotel Dieu de France Hospital
Conditions:
Pediatric Obstructive Sleep Apnea
Eligibility:
All Genders
18-8 years
Phase:
NA
Brief Summary
This prospective interventional clinical trial (non-randomized) aims to evaluate oral corticosteroids' role as an alternative to surgery (gold-standard) in the treatment of obstructive sleep apnea in ...
Eligibility Criteria
Inclusion
- All children aged between 18 months and 8 years diagnosed with OSAS secondary to adenotonsillar hypertrophy
Exclusion
- Children under 18 months or over 8 years old
- History of acute or chronic cardiorespiratory neuromuscular, or metabolic diseases
- Congenital craniofacial anomalies
- Chromosomal disorders
- Epilepsy
Key Trial Info
Start Date :
December 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT06917768
Start Date
December 9 2022
End Date
December 15 2023
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu de France
Beirut, Lebanon